ConductScience.org, home

Paper12324809

Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians.

Ashikaga T and 3 others. Support Care Cancer, 2002. Cited by 125 papers, by iCite.

Cite this record

ConductScience Library. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Papers, record 12324809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12324809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians.
PubMed
Journal
Support Care Cancer
PubMed
Year
2002
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
125
iCite
Relative citation ratio, by iCite
4.33
iCite
Revised in PubMed
2022-03-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ashikaga TTaka
2Bosompra KKwadwo
3O'Brien PPatricia
4Nelson LLee

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Complementary TherapiesMajor topic
PhysiciansMajor topic
Adult
Aged
Aged, 80 and over
Communication
Factor Analysis, Statistical
Female
Humans
Logistic Models
Middle Aged
Patient Acceptance of Health Care
Surveys and Questionnaires
Vermont

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA22435NCI NIH HHSUnited StatesP30CA022435PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.

PMIDTitleJournalYearIn PapersSource
42444835Systems approach to integrative oncology in breast cancer care: service design, delivery and patient experiences from a UK center.Front Oncol2026https://conductscience.org/library/papers/42444835PubMed
40159696Secrets and Their Consequences in Heathcare: A Scoping Review of Worker Experiences.J Adv Nurs2026https://conductscience.org/library/papers/40159696PubMed
39108243A survey of patients with cancer and oncology health-care professionals about cannabis use during treatment.J Natl Cancer Inst Monogr2024https://conductscience.org/library/papers/39108243PubMed
38894516Assessment of Undergraduate Nursing Students' Understanding of Herbal Medicines and Herb-Drug Interactions in Riyadh, Saudi Arabia.Med Sci Monit2024https://conductscience.org/library/papers/38894516PubMed
38405305An Integrative Medicine Educational Program for Radiation Oncology Patients: Patient-Reported Outcomes.Adv Radiat Oncol2024https://conductscience.org/library/papers/38405305PubMed
35596542Prevalence, Beliefs, and the Practice of the Use of Herbal and Dietary Supplements Among Adults in Saudi Arabia: An Observational Study.Inquiry2022https://conductscience.org/library/papers/35596542PubMed
34055029Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/34055029PubMed
31205497Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.Ther Adv Med Oncol2019https://conductscience.org/library/papers/31205497PubMed
29619352Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.Plast Surg (Oakv)2017https://conductscience.org/library/papers/29619352PubMed
29379382Indicators for Medical Mistrust in Healthcare-A Review and Standpoint from Southeast Asia.Malays J Med Sci2017https://conductscience.org/library/papers/29379382PubMed
29338443Barriers to Acupuncture Use Among Breast Cancer Survivors: A Cross-Sectional Analysis.Integr Cancer Ther2018https://conductscience.org/library/papers/29338443PubMed
29218996Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report From the MyBCC Study.Integr Cancer Ther2018https://conductscience.org/library/papers/29218996PubMed
27729739Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis.World J Gastroenterol2016https://conductscience.org/library/papers/27729739PubMed
27433182Complementary and Alternative Medicine Use and Its Association with Quality of Life among Cancer Patients Receiving Chemotherapy in Ethiopia: A Cross-Sectional Study.Evid Based Complement Alternat Med2016https://conductscience.org/library/papers/27433182PubMed
27075675Oncologists' experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis.Support Care Cancer2016https://conductscience.org/library/papers/27075675PubMed
26585912Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer.BMC Complement Altern Med2015https://conductscience.org/library/papers/26585912PubMed
26430614A Study on the Characteristics of Infrequent and Frequent Outpatients Visiting Korean Traditional Medical Facilities.Osong Public Health Res Perspect2015https://conductscience.org/library/papers/26430614PubMed
25865412An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits.Patient Educ Couns2015https://conductscience.org/library/papers/25865412PubMed
25749602Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.J Natl Cancer Inst Monogr2014https://conductscience.org/library/papers/25749602PubMed
25628834Evaluation of effectiveness of herbal medication in cancer care: a review study.Iran J Cancer Prev2012https://conductscience.org/library/papers/25628834PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12324809

GET https://conductscience.org/api/papers/v1/12324809/cited_by?page=2